Biologicals - World Health Organization (WHO)
6 days ago · Biologicals are a class of medicines made from living cells taken from plants, animals or bacteria. These cells are use in creating many types of health care products, including …
Biosimilars: expanding access to essential biologic therapies
Feb 13, 2025 · Biologic medicines have transformed treatment for numerous chronic and life-threatening conditions such as cancer, auto-immune diseases, and diabetes. These therapies …
Call for applications closed - 2025 Introductory course for …
Jan 23, 2025 · Course Period Proposed dates for the 2025 Introductory Course for Biologics Development and Manufacturing are: Monday, June 16, 2025 – Friday, June 27, 2025 (2 …
Guidelines for Biologicals - World Health Organization (WHO)
Nov 19, 2004 · Guidelines for the production and control of inactivated oral cholera vaccine, Annex 3, TRS No 924 Guidelines for the production and control of inactivated oral...
Introductory course for biologics development and manufacturing
Jun 27, 2025 · In-person (by application)Date: 16-27 June 2025 (two-week course) Languages: English Low- and middle-income countries (LMICs) face significant inequity in terms of access …
2025 Hands On Training for Upstream Processin Cell Based …
Apr 24, 2025 · The hub's mandate is to provide training in the manufacturing of high-quality vaccines and biologics in an industrial setting, aiming to resolve inequality in access to …
Good manufacturing practices (GMP) for biological products were first published by WHO in 1992 (1). This current revision reflects subsequent developments that have taken place in science …
WHO adds LC16m8 mpox vaccine to Emergency Use Listing
Oct 31, 2024 · This is the largest donation package announced to date in response to the current mpox emergency. LC16m8 is a vaccine developed and manufactured by KM Biologics in …
Introductory Course for Biologics Development and Manufacturing ...
Jan 15, 2024 · Low- and Middle-Income Countries (LMICs) face significant inequity in terms of access to vaccines and other biologics and are making efforts to establish biological …
Medigen License to C-TAP - World Health Organization (WHO)
In July 2023, under the auspices of WHO’s COVID-19 Technology Access Pool (C-TAP), the Medicines Patent Pool signed a worldwide license with Medigen Vaccine Biologics Corp. …